New Drug Product: Belsomra

Treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance.

Hacked Health: Security, Connected Medical Devices

n recent years, concerns over security and data breaches have led government agencies to consider a stronger regulatory role in ensuring that connected medical devices are not at risk of being “hacked” for unauthorized use and access.

More Strawberries, More Heart Benefits?

Two new studies suggest that consuming 3–4 servings of strawberries per day can lower risk factors for diabetes and cardiovascular disease.

First Breath-Actuated, Dry-Powder Inhaler for Asthma

Teva announced that the FDA has approved ProAir RespiClick (albuterol sulfate inhalation powder), the first breath-actuated dry-powder inhaler approved for acute asthma symptoms.

Having the Statin Conversation

A new report provides clinicians with a guideline on how to help patients decide whether or not to initiate statin therapy.

New Brilinta Administration Option

The Food and Drug Administration (FDA) has approved a new administration option for Brilinta (ticagrelor; AstraZeneca) for patients who are unable to swallow the 90mg tablets whole.

Looking for a Job?

Access our job board to view over 1,​40​0 job openings throughout the US.

Evidence-Based Care for Atrial Fibrillation

The Preventive Cardiovascular Nurses Association is pleased to provide Evidence-Based Care of the Patient with Atrial Fibrillation: A Call to Action for Nurses and Advanced Practice Nurses. This series of articles is designed to guide and support the clinical practice of those managing patients with atrial fibrillation (AF), the most common cardiac arrhythmia in the United States.

Latest News


Make prescribing decisions with our comparative charts and treatment algorithms. See our recently added and updated charts below.

Download or print easy-to-read disease/condition leaflets for your patients. See our recently added patient information fact sheets below.

Sign Up for Free e-newsletters